The single positron emission computed tomography/computed tomography (SPECT/CT) segment, and its ability to provide diagnostic CT, leads this charge and opens up numerous lucrative opportunities in niche market such as neuroendocrine tumor imaging.
New analysis from Frost & Sullivan (medicalimaging.frost.com), North American Nuclear Medicine Equipment Market, finds that the market earned revenues of $298.4 million in 2007 and estimates this to reach $325.3 million in 2014.
If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the North American Nuclear Medicine Equipment Market, then send an email to Melina Trevino, Corporate Communications, at mtrevino_pr[.]frost.com, with your full name, company name, title, telephone number, company email address, company website, city, state and country. Upon receipt of the above information, an overview will be sent to you via email.
With the new attenuation correction and image acquisition/reconstruction tools having enhanced SPECT/CT end users' confidence in its diagnostic and prognostic capabilities, SPECT/CT is fast becoming a must-have technology.
"With the adoption rate of SPECT/CT progressively increasing, opening up new market potential for both imaging system vendors and radiopharmaceutical agent companies," says Frost & Sullivan Research Analyst Travis Chong. "The rising numbers of new niche markets expect to drive growth in this segment, creating opportunities for revenue expansion and establishing SPECT/CT as a mainstream tool in nuclear medicine."
Participants in niche markets have to contend with the peculiar dynamics of such markets as well as prepare to deal with challenges arising from the lack of novel imaging agents. SPECT/CT could experience slow clinical adoption due to reimbursement reductions, tight end-user capital budgets, narrow physician referral bases, and low levels of physician education.
"Vendors could also be significantly hindered by the inadequate technologist training for specialty markets," notes Chong. "However, they can improve this issue by working with its consumers to offer informative training programs. This way, vendors will not only enhance physician education and technologist training levels, but also manage to strengthen its brand loyalty and recognition, which in turn, will translate into increased revenue potential."
Once they manage to convey the importance of SPECT and SPECT/CT equipment to end users, vendors will look to phase out traditional product models with scalable system platforms. They expect a bigger market for scalable platforms due to their increased clinical versatility that enables end users to adapt their systems to meet their needs, as workflow demands and imaging operations continuously evolve.
"Companies should also look to increase both organic and external R&D investments in solid-state technology and scintillation detection," observes Chong. "Solid-state technology has proven to have high reliability, low manufacturing costs and less noise, high sensitivity, as well as excellent spatial and energy resolution."
In future, the integration of solid-state technology will also advance hybrid technology and drive product innovation, creating novel systems such as SPECT/MRI.
North American Nuclear Medicine Equipment Market is part of the Medical Imaging Growth Partnership Service program, which also includes research in the following markets: U.S. medical displays market, U.S. cardiology picture archiving and communications systems (PACS) market, and U.S. cardiac and vascular x-ray imaging equipment markets. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.
Frost & Sullivan, the Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting, and Career Best Practices empower clients to create a growth focused culture that generates, evaluates, and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.
North American Nuclear Medicine Equipment Market